Healthcare provider profile · identity verified

Christopher Ryan Stetler, D.O.

Family Practice · UNIONTOWN, OH · NPI 1891725537

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	690	147
Amlodipine Besylate	Amlodipine Besylate	562	163
Atorvastatin Calcium	Atorvastatin Calcium	551	145
Lisinopril	Lisinopril	451	112
Omeprazole	Omeprazole	431	99
Rosuvastatin Calcium	Rosuvastatin Calcium	355	111
Gabapentin	Gabapentin	302	67
Losartan Potassium	Losartan Potassium	281	76
Pantoprazole Sodium	Pantoprazole Sodium	277	89
Metformin Hcl Er	Metformin Hcl	240	44
Metoprolol Tartrate	Metoprolol Tartrate	197	48
Fluticasone Propionate	Fluticasone Propionate	193	76
Metformin Hcl	Metformin Hcl	192	48
Metoprolol Succinate	Metoprolol Succinate	183	54
Sertraline Hcl	Sertraline Hcl	173	49
Carvedilol	Carvedilol	167	44
Simvastatin	Simvastatin	149	38
Albuterol Sulfate Hfa	Albuterol Sulfate	148	43
Furosemide	Furosemide	148	45
Tamsulosin Hcl	Tamsulosin Hcl	147	46
Eliquis	Apixaban	139	33
Trazodone Hcl	Trazodone Hcl	137	31
Hydralazine Hcl	Hydralazine Hcl	135	16
Hydrochlorothiazide	Hydrochlorothiazide	133	43
Famotidine	Famotidine	132	33
Fluoxetine Hcl	Fluoxetine Hcl	122	28
Pravastatin Sodium	Pravastatin Sodium	121	34
Clopidogrel	Clopidogrel Bisulfate	120	29
Duloxetine Hcl	Duloxetine Hcl	116	28
Tizanidine Hcl	Tizanidine Hcl	112	30
Montelukast Sodium	Montelukast Sodium	107	24
Potassium Chloride	Potassium Chloride	107	29
Atenolol	Atenolol	106	27
Allopurinol	Allopurinol	105	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	21
Meloxicam	Meloxicam	100	28
Escitalopram Oxalate	Escitalopram Oxalate	92	23
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	81	12
Alendronate Sodium	Alendronate Sodium	80	25
Tramadol Hcl	Tramadol Hcl	76	20
Jardiance	Empagliflozin	75	25
Quetiapine Fumarate	Quetiapine Fumarate	75	15
Citalopram Hbr	Citalopram Hydrobromide	73	21
Glipizide Er	Glipizide	72	21
Hydroxyzine Hcl	Hydroxyzine Hcl	71	25
Clonazepam	Clonazepam	67	suppressed
Bupropion Xl	Bupropion Hcl	63	11
Alprazolam	Alprazolam	61	15
Ozempic	Semaglutide	61	11
Chlorthalidone	Chlorthalidone	60	16
Ezetimibe	Ezetimibe	56	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	suppressed
Tradjenta	Linagliptin	56	suppressed
Valsartan	Valsartan	54	15
Pregabalin	Pregabalin	53	suppressed
Prednisone	Prednisone	52	31
Aripiprazole	Aripiprazole	51	13
Mirtazapine	Mirtazapine	51	11
Buspirone Hcl	Buspirone Hcl	50	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	13
Azelastine Hcl	Azelastine Hcl	46	26
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	43	11
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Irbesartan	Irbesartan	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	14
Ondansetron Hcl	Ondansetron Hcl	41	11
Topiramate	Topiramate	41	suppressed
Nebivolol Hcl	Nebivolol Hcl	39	suppressed
Celecoxib	Celecoxib	38	13
Spironolactone	Spironolactone	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	11
Donepezil Hcl	Donepezil Hcl	36	suppressed
Brilinta	Ticagrelor	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Gemfibrozil	Gemfibrozil	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	11
Naproxen	Naproxen	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Linzess	Linaclotide	29	suppressed
Temazepam	Temazepam	29	suppressed
Cephalexin	Cephalexin	28	22
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Desmopressin Acetate	Desmopressin Acetate	25	suppressed
Diazepam	Diazepam	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Glipizide	Glipizide	24	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	20
Trulicity	Dulaglutide	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Finasteride	Finasteride	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Repatha Syringe	Evolocumab	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Colchicine	Colchicine	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Niacin Er	Niacin	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Bydureon Bcise	Exenatide Microspheres	15	suppressed
Humalog Kwikpen U-200	Insulin Lispro	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Baclofen	Baclofen	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Constulose	Lactulose	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Fetzima	Levomilnacipran Hcl	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error